Now in its 7th year, this is the undisputed (and only!) meeting dedicated to harnessing emerging biological understanding, employing novel preclinical models to cement translational confide
With the recent FDA approval of SYFOVRE and more decisions and approvals expected in 2023, the Complement-Based Drug Development Summit is returning for
Accelerate Clinical Proof of Concept for the Future of Cell Therapy & Regenerative Medicine. Benchmark Clinical Translation to Advance Safe Differentiation, Gene-Editing and Manufacturing Efficiency to Fast-Track Regulatory Submissions.